• • Company Profile
  • Executive Management
  • Board of Directors
  • Scientific Advisory Board
  • NexMed USA
  • TOTECT
• • NexACT®
  • DDAIP.HCl Properties
  • DDAIP.HCl Molecular Interactions
  • DDAIP: Mechanism of Action
  • NexACT® Diagram
  • Publications
• • Sexual Dysfunction
  • Oncology
  • Autoimmune/Anti-Inflammatory/Pain
  • Anti-Infectives & Cosmeceuticals
  • Metabolic Diseases
  • TOTECT
• • Stock Quotation
  • Interactive Chart
  • Fact Sheet
  • SEC Filings
  • SEC Filings - XBRL Content
  • Corporate Governance
  • Corporate Presentation
  • Social Media
• • Media & Events
  • Press Releases

Home | Search

Content

Apricus Bio will use reasonable efforts to include accurate and up-to-date information on this web site but Apricus Bio makes no warranties or representations of any kind as to its accuracy or completeness. You agree that access to and use of this web site and the content thereof is at your own risk. Apricus Bio disclaims all warranties, express or implied, including warranties of merchantability of fitness for a particular purpose.
Neither Apricus Bio nor any party involved in creating, producing or delivering this web site shall be liable for any damages, including without limitation, direct, incidental, consequential, indirect or punitive damages, arising out of access to, use of or inability to use this web site, or any errors or omissions in the content thereof. This limitation includes damages to, or for any viruses that infect your computer equipment.

Forward-looking Language Statement

This web site may contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to its ability to enter into partnering agreements or raise financing on acceptable terms, successful completion of clinical development programs, regulatory review and approval, product development and acceptance, manufacturing, competition, and/or other factors, some of which are outside the control of the Company.